signal/raiseTrack rounds
Sector brief

Healthtech & bio startup funding in 2026

Every Healthtech & bio round we tracked this year: the biggest raises, active investors and where the money went.

Research desk · data to 5 November 2026
Raised$8.23bn
Rounds60
Median round$35m
$100m+ rounds22

We tracked 60 startup funding rounds in Healthtech & bio so far in 2026, together worth $8.23bn in disclosed funding. The median disclosed round was $35m.

The largest was Isomorphic Labs's $2.1bn Series B round, led by Thrive Capital. 22 rounds reached $100m or more and accounted for 88% of the money.

By region, Europe took $4.83bn (59%).

4 companys raised at a valuation of $1bn or more: Pathos AI, Precision Neuroscience, Enveda, Alan.

The biggest rounds

  1. 1Isomorphic LabsSeries B · Healthtech & bio · London$2.1bn
  2. 2Neko HealthSeries C · Healthtech & bio · Stockholm$700m
  3. 3AlanSeries D+ · Healthtech & bio · Paris$552m
  4. 4CMR SurgicalGrowth · Healthtech & bio · Cambridge$400m
  5. 5AdvanCellSeries D+ · Healthtech & bio · Brisbane$315m
  6. 6EnvedaSeries D+ · Healthtech & bio · Boulder$311m
  7. 7OMass TherapeuticsSeries C · Healthtech & bio · Oxford$310m
  8. 8Encoded TherapeuticsSeries D+ · Healthtech & bio · South San Francisco$275m
  9. 9Precision NeuroscienceSeries D+ · Healthtech & bio · New York$250m
  10. 10Pathos AISeries D+ · Healthtech & bio · New York$237m

Figures cover the rounds in our tracker, which records disclosed amounts converted to US dollars at announcement. See the methodology.

Related reports and rankings